MRKR – Marker Therapeutics Inc
Float Short %
2.31
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
0.27
EPS This/Next Y
0.31
Price
1.32
Target Price
6
Analyst Recom
1
Performance Q
50.98
Relative Volume
1.31
Beta
1.38
Ticker: MRKR
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | MRKR | 0.955 | N/A | N/A | 0 |
| 2025-11-11 | MRKR | 0.9268 | N/A | N/A | 0 |
| 2025-11-12 | MRKR | 0.9435 | N/A | N/A | 0 |
| 2025-11-13 | MRKR | 0.892 | N/A | N/A | 0 |
| 2025-11-14 | MRKR | 0.9205 | N/A | N/A | 0 |
| 2025-11-17 | MRKR | 0.9712 | N/A | N/A | 0 |
| 2025-11-18 | MRKR | 0.9975 | N/A | N/A | 0 |
| 2025-11-19 | MRKR | 1.08 | N/A | N/A | 0 |
| 2025-11-20 | MRKR | 1 | N/A | N/A | 0 |
| 2025-11-21 | MRKR | 1.07 | N/A | N/A | 0 |
| 2025-11-24 | MRKR | 1.11 | N/A | N/A | 0 |
| 2025-11-25 | MRKR | 1.11 | N/A | N/A | 0 |
| 2025-11-26 | MRKR | 1.23 | N/A | N/A | 0 |
| 2025-12-01 | MRKR | 1.18 | N/A | N/A | 0 |
| 2025-12-02 | MRKR | 1.2 | N/A | N/A | 0 |
| 2025-12-03 | MRKR | 1.26 | N/A | N/A | 0 |
| 2025-12-04 | MRKR | 1.41 | N/A | N/A | 0 |
| 2025-12-05 | MRKR | 1.34 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | MRKR | 0.97 | 19.2 | - | -1.08 |
| 2025-11-11 | MRKR | 0.93 | 19.2 | - | -1.08 |
| 2025-11-12 | MRKR | 0.94 | 19.2 | - | -1.08 |
| 2025-11-13 | MRKR | 0.89 | 19.2 | - | -1.08 |
| 2025-11-14 | MRKR | 0.95 | 19.2 | - | -1.08 |
| 2025-11-17 | MRKR | 0.97 | 19.2 | - | -1.08 |
| 2025-11-18 | MRKR | 1.00 | 19.2 | - | -1.08 |
| 2025-11-19 | MRKR | 1.09 | 19.2 | - | -1.08 |
| 2025-11-20 | MRKR | 1.00 | 19.2 | - | -1.08 |
| 2025-11-21 | MRKR | 1.07 | 57.1 | - | -0.92 |
| 2025-11-24 | MRKR | 1.11 | 57.1 | - | -0.92 |
| 2025-11-25 | MRKR | 1.10 | 57.1 | - | -0.92 |
| 2025-11-26 | MRKR | 1.24 | 57.1 | - | -0.92 |
| 2025-12-01 | MRKR | 1.17 | 57.1 | - | -0.92 |
| 2025-12-02 | MRKR | 1.19 | 57.1 | - | -0.92 |
| 2025-12-03 | MRKR | 1.27 | 57.1 | - | -0.92 |
| 2025-12-04 | MRKR | 1.41 | 57.1 | - | -0.92 |
| 2025-12-05 | MRKR | 1.32 | 57.1 | - | -0.92 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | MRKR | 0.00 | -7.38 | 2.90 |
| 2025-11-11 | MRKR | 0.00 | -7.38 | 2.90 |
| 2025-11-12 | MRKR | 0.00 | -7.38 | 2.55 |
| 2025-11-13 | MRKR | 0.00 | -7.38 | 2.55 |
| 2025-11-14 | MRKR | 0.00 | -7.38 | 2.55 |
| 2025-11-17 | MRKR | 0.00 | -0.46 | 2.55 |
| 2025-11-18 | MRKR | 0.00 | -0.46 | 1.98 |
| 2025-11-19 | MRKR | 0.00 | -0.46 | 1.98 |
| 2025-11-20 | MRKR | 0.00 | -0.46 | 1.98 |
| 2025-11-21 | MRKR | 0.00 | -0.46 | 1.99 |
| 2025-11-24 | MRKR | 0.00 | 0.40 | 1.99 |
| 2025-11-25 | MRKR | 0.00 | 0.40 | 1.99 |
| 2025-11-26 | MRKR | 0.00 | 0.40 | 2.31 |
| 2025-12-01 | MRKR | 0.00 | 0.40 | 2.31 |
| 2025-12-02 | MRKR | 0.00 | 0.40 | 2.31 |
| 2025-12-03 | MRKR | 0.00 | 0.40 | 2.31 |
| 2025-12-04 | MRKR | 0.00 | 0.40 | 2.31 |
| 2025-12-05 | MRKR | 0.00 | 0.40 | 2.31 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.12
Avg. EPS Est. Current Quarter
-0.18
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
0.4
Beta
1.38
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
20
Growth Score
29
Sentiment Score
54
Actual DrawDown %
96.5
Max Drawdown 5-Year %
-98
Target Price
6
P/E
Forward P/E
PEG
P/S
4.69
P/B
1.2
P/Free Cash Flow
EPS
-1.23
Average EPS Est. Cur. Y
-0.92
EPS Next Y. (Est.)
-0.61
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-304.54
Relative Volume
1.31
Return on Equity vs Sector %
-104.7
Return on Equity vs Industry %
-89.8
EPS 1 7Days Diff
0.2
EPS 1 30Days Diff
0.16
EBIT Estimation
Marker Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading